Plasmodium falciparum heme metabolism pathway

The *Plasmodium falciparum heme metabolism pathway* collectively refers to two key metabolic processes in the malaria parasite: **de novo heme biosynthesis** and **heme detoxification**. Parasites digest host hemoglobin in their intraerythrocytic stage, releasing large amounts of free heme, which is toxic. *P. falciparum* neutralizes heme by crystallizing it as hemozoin, aided by enzymes such as heme detoxification protein (HDP)[1][7]. The parasite also encodes a complete heme biosynthesis pathway involving mitochondrial, apicoplast, and cytosolic enzymes[2][5][7], producing heme for essential cofactor roles (e.g., electron transport chain, cytochromes). However, recent genetic studies demonstrate that this biosynthetic pathway is dispensable during the blood stage (parasites scavenge sufficient host heme), but essential for mosquito-stage development and parasite transmission[2][3][4][5][7]. The pathway is a longstanding antimalarial drug target: agents like quinolines block hemozoin formation, while recent strategies attempt to exploit heme biosynthesis for parasite-selective toxicity[6][3]. Accumulation of free heme and its metabolites are linked to malaria severity and parasite/host toxicity. Despite its critical roles, only aspects of heme detoxification are viable targets for blood-stage malaria therapy; biosynthetic enzymes become essential in the mosquito stage, suggesting their primary value as transmission-blocking drug targets. Note on correctness: This entry describes a **pathway**, not a single defined gene or protein target; thus, it is not a canonical receptor or molecular target in the strict sense, and is too broad for precision targeting. Individual components of the pathway (e.g., HDP, ferrochelatase, or heme O synthase) can be considered molecular targets, and it may be advisable to focus future data curation at that level for structured therapeutic information[6][7].

Other names

Heme biosynthesis pathway in Plasmodium falciparumP. falciparum heme biosynthesisMalaria parasite heme pathwayHeme detoxification pathway (collective term)

Artemisinins: interact with heme or ferrous iron to produce cytotoxic radicals when hemoglobin is digested, damaging parasite proteins/lipids Quinoline antimalarials: inhibit hemozoin (malaria pigment) formation, causing toxic free heme to accumulate in food vacuole, resulting in parasite death[6] Atovaquone: inhibits cytochrome bc1, blocking electron transport pathway dependent on heme[5] Chemicals that stimulate heme biosynthesis (e.g., ALA) may cause accumulation of toxic intermediates, leading to photodynamic or oxidative damage[3]